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Abstract
Background: ATP-sensitive potassium (KATP) channels in neurons mediate neuroprotection, they regulate
membrane excitability, and they control neurotransmitter release. Because loss of DRG neuronal KATP currents is
involved in the pathophysiology of pain after peripheral nerve injury, we characterized the distribution of the KATP
channel subunits in rat DRG, and determined their alterations by painful axotomy using RT-PCR,
immunohistochemistry and electron microscopy.
Results: PCR demonstrated Kir6.1, Kir6.2, SUR1 and SUR2 transcripts in control DRG neurons. Protein expression for
all but Kir6.1 was confirmed by Western blots and immunohistochemistry. Immunostaining of these subunits was
identified by fluorescent and confocal microscopy in plasmalemmal and nuclear membranes, in the cytosol, along
the peripheral fibers, and in satellite glial cells. Kir6.2 co-localized with SUR1 subunits. Kir6.2, SUR1, and SUR2
subunits were identified in neuronal subpopulations, categorized by positive or negative NF200 or CGRP staining.
KATP current recorded in excised patches was blocked by glybenclamide, but preincubation with antibody against
SUR1 abolished this blocking effect of glybenclamide, confirming that the antibody targets the SUR1 protein in the
neuronal plasmalemmal membrane.
In the myelinated nerve fibers we observed anti-SUR1 immunostaining in regularly spaced funneled-shaped struc-
tures. These structures were identified by electron microscopy as Schmidt-Lanterman incisures (SLI) formed by the
Schwann cells. Immunostaining against SUR1 and Kir6.2 colocalized with anti-Caspr at paranodal sites.
DRG excised from rats made hyperalgesic by spinal nerve ligation exhibited similar staining against Kir6.2, SUR1 or
SUR2 as DRG from controls, but showed decreased prevalence of SUR1 immunofluorescent NF200 positive neu-
rons. In DRG and dorsal roots proximal to axotomy SLI were smaller and showed decreased SUR1
immunofluorescence.
Conclusions: We identified Kir6.2/SUR1 and Kir6.2/SUR2 KATP channels in rat DRG neuronal somata, peripheral
nerve fibers, and glial satellite and Schwann cells, in both normal state and after painful nerve injury. This is the
first report of KATP channels in paranodal sites adjacent to nodes of Ranvier and in the SLI of the Schwann cells.
After painful axotomy KATP channels are downregulated in large, myelinated somata and also in SLI, which are also
of smaller size compared to controls.
Because KATP channels may have diverse functional roles in neurons and glia, further studies are needed to
explore the potential of KATP channels as targets of therapies against neuropathic pain and neurodegeneration.
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Background
ATP- sensitive potassium (KATP) channels are octamers
made of four pore-forming inward rectifiers (Kir) that
co-assemble with four regulatory sulfonylurea receptor
(SUR) subunits [1,2]. Different tissue-specific subunit
combinations have been identified that include Kir6.2/
SUR1 (pancreatic), Kir6.2/SUR2A (cardiac), and Kir6.1
(or Kir6.2)/SUR2B (vascular smooth muscle) subtype.
KATP channels are inhibited by physiological [ATP]i,
and are activated when the intracellular ADP/ATP ratio
increases as a result of energy depletion secondary to
hypoxia, ischemia or metabolic stress [3,4]. Their activa-
tion results in K+ efflux, leading to membrane hyperpo-
larization, decreased excitability, attenuation of
transmitter release, and protection from cell death in
heart [5] and brain [2]. KATP channels also act as trans-
ducers and effectors of neuronal preconditioning [6].
We have recently reported that DRG neurons express
KATP currents that decrease after painful nerve injury
[7-10]. The loss of KATP current contributes to neuro-
pathic pain through increased membrane excitability,
amplified neurotransmitter release [9], and possibly
increased susceptibility to cell death. Despite the impor-
tance of KATP channels in normal and pathological func-
tion, their expression has not been investigated in
peripheral sensory pathways. Therefore, we character-
ized the distribution of the subunits of KATP channels in
DRG, and identified alterations in their expression and
distribution following painful nerve injury.
Methods
Animals
All procedures were approved by the Animal Care and
Use Committee (IACUC) of the Medical College of
Wisconsin.
Induction of Experimental Neuropathic Pain
We randomized male Sprague-Dawley rats (120-140 g)
by chance either to a spinal nerve ligation (SNL) or to a
control group. All surgical procedures were performed
under general anesthesia with isoflurane 1.5-2% in O2.
Ligation of the lumbar 5th and 6th spinal nerve was per-
formed by the technique of Kim and Chung [11], as we
have described previously [8-10].
Behavioral Testing, Tissue Harvesting and Cell
Dissociation
Neuropathic pain following SNL was confirmed by
behavioral testing for ipsilateral mechanical hyperalgesia
at the 10th, 12th and the 14th day after surgery [8,12].
After 30 min of rest we applied the tip of a 22 gauge
spinal needle on the plantar surface of both hind paws
in random order with pressure adequate to indent but
not penetrate the plantar skin. Each needle application
produced either a normal brief reflexive paw withdrawal,
or a hyperalgesia-type response that included sustained
(> 1 s) paw lifting, shaking, and grooming [12]. Rats
with probability of hyperalgesia ≥ 20% were considered
as expressing neuropathic pain phenotype. These consti-
tuted 81% of the animals subjected to SNL. We deter-
mined that this threshold of 20% ensures optimal
sensitivity and specificity for detecting neuropathic pain
phenotype after SNL based on analysis of receiver oper-
ating plots from previous studies [12].
Dorsal root ganglia were harvested between the 17th
and 28th day after control or SNL operation, from rats
euthanatized by decapitation under deep isoflurane
anesthesia. For the electrophysiological experiments and
confocal microscopy studies, we dissociated DRG neu-
rons as described previously [8].
RT-PCR for KATP Channel Subunits
Total mRNA was isolated from neurons dissociated
from one L5 control DRG at each time. For cell isola-
tion each ganglion was enzymatically dissociated in 0.5
ml DMEM/F12 (Dulbecco’s modified Eagle’s medium
F12; Gibco, Invitrogen Corp., Carlsbad, CA) with 0.025%
w:v liberase blendzyme 2 (Roche Diagnostics Corp.,
Indianapolis, IN) for 30 min in an incubator at 37°C.
After centrifugation and removal of the supernatant, a
second incubation at 37°C followed for another 30 min
in 0.25 ml DMEM with 0.0625% trypsin from bovine
pancreas (10,000-15,000 BAEE units/mg protein; Sigma,
St. Louis, MO; Cat.No. T8802) and 0.0125% deoxyribo-
nuclease 1 from bovine pancreas (≥ 2,000 Kunitz units/
mg protein; Sigma, St. Louis, MO; Cat.No. D5025) in
0.25 ml DMEM.
After adding 0.25 ml trypsin inhibitor 0.1% w:v
(Sigma), cells were centrifuged (600 rpm for 5 min). For
RNA isolation cells were treated with TRIzol reagent
(Invitrogen Life Technology) following the supplier’s
protocol. Isolated RNA was incubated with DNAse
(Ambion, Austin, TX) to eliminate DNA contamination,
and then 1.2 μg RNA was used for cDNA generation
using the Retroscript Synthesis Kit (Ambion). The seg-
ment of interest was reverse-transcribed for 2 hours at
42°C.
PCR was performed with 1.5 μl cDNA in total 25 μl
using specific primers for Kir6.1 [forward (fw): GGA-
TAATCCCATCGAGAGCA, reverse (rv): CTCAGC-
CACTGACCTTGTCA), Kir6.2 (fw:
TCCAACAGCCCGCTCTAC, rv: CAGCGTTTTGTCCC-
CATC), SUR1 (fw: TGAAGCAACTGCCTCCATC, rv:
GACAAGCCGGAAAAGCTTC) or SUR2 (fw:
ACCTGCTCCAGCACAAGAAT, rv: CCTGGTCATTGT-
GATGAAGAGA)] and Taq DNA polymerase (Roche).
The 35 cycles included initial denaturation at 94°C, 4 min;
94°C, 10 sec; 56°C, 30 sec; 72°C, 2 min; and final extension
72°C, 10 min. In negative control experiments reverse
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transcriptase was omitted. PCR products (12 μl) were sepa-
rated by electrophoresis on a 1.5% agarose gel stained with
ethidium bromide and visualized with a Molecular Imager
(Bio-Rad, Hercules, CA). The analysis was repeated with
neurons dissociated from DRG of three different control
rats.
Western blotting
Dorsal root ganglia, brain and pancreas from control
rats were immediately frozen in liquid nitrogen after
removal and stored in -80°C. After thawing in ice, they
were homogenized in 100 μl lysis buffer (in mM: 20
MOPS, 2 EGTA, 5 EDTA, 30 NaF, 40 b-glyceropho-
sphate, 10 Na-pyrophoshate, 0.5% NP-40). Samples were
prepared for SDS-PAGE by 1:1 dilution with Laemmli
buffer, and 30 μg of protein was loaded in each well.
Staining with Ponceau S solution was used to verify pro-
tein transfer and protein loading to a PVDF membrane.
Blots were incubated with 5% non-fatty dry milk
(NFDM), 3% bovine serum albumin in 0.1% TBS-T solu-
tion for 1 h and then with antibodies (1:200) against
SUR1, SUR2, Kir6.2 and Kir6.1, in 1% NFDM overnight
at 4°C. Three 15 min washes in TBS-T followed before
staining with each secondary antibody (goat anti rabbit
HRP-IgG, Santa Cruz 1:10.000) for 2 h, at room tem-
perature. The ECL-Plus chemiluminescence detection
kit was used to detect the antigen-HRP conjugated anti-
body complex (GE Healthcare, Amersham, PA). Each
determination was performed 3 times with tissue from
different animals.
Immunohistochemistry
Dorsal root ganglia were cryoprotected in 4% PFA with
15% sucrose in 0.1 M PBS for 1 h, followed by 30%
sucrose in 0.1 M PBS overnight. Subsequently DRG
embedded in Tissue-Tek® OCT, were sectioned (5 or 12
μm) with a Leica cryostat (Jung CM 1800; Vienna, Aus-
tria), plated onto Gatenby’s solution subbed slides, and
post-fixed in 4% PFA with 4% sucrose. After blocking
with 4% normal goat serum for 1 h at room tempera-
ture, slides were incubated in polyclonal rabbit antibo-
dies to Kir6.1, Kir6.2 (1:500, Alomone, Jerusalem, Israel),
and SUR1 or SUR2 (1:50, Santa Cruz Biotechnology,
Santa Cruz, CA). Some samples were also co-labeled
with antibodies against neurofilament 200 (NF 200;
1:1000, Abcam, Cambridge, UK) and calcitonin-gene
related peptide (CGRP; 1:50; Santa Cruz). The nodes of
Ranvier were identified with contactin-associated protein
1 (Caspr, 1:500; clone K65/35, UC Davis/NINDS/NIMH
NeuroMab Facility, University of California, Davis, CA
95616), which is localized in paranodal sites [13,14].
Samples were incubated at 4°C overnight. After series of
washes, samples were stained with goat anti-rabbit
Texas Red (1:500, Jackson Immunoresearch, USA), or
goat anti-rabbit Alexa 546 (1:500, Molecular Probes,
USA), or goat anti-mouse Alexa Fluor 488 (1:1000,
Molecular Probes, USA) as secondary antibodies. DAPI
(1:1000; Sigma, St Louis, MO, USA) was used for
nuclear staining to distinguish neuronal somata from
satellite glial cells. All antibodies were diluted in 1 ×
GDB containing 0.3% Triton. Slides were mounted with
Shur/Mount medium and cover-slipped. For negative
controls, only the secondary antibodies were applied.
Rat pancreas, brain, and vascular tissues were used as
positive controls.
To identify that the pore forming Kir6.2 subunits co-
localize with the regulatory SUR1 subunits in DRG as
they do in other tissues, we co-labeled some samples
with antibody against Kir6.2, with FITC conjugated-gly-
benclamide (ER-Tracker Green BODIPY-Glybenclamide,
Molecular Probes) [15], and with DAPI. Specifically, fro-
zen sections treated with anti-Kir6.2 were incubated
with BODIPY-Glybenclamide (20 nM) in 0.1 M PBS for
60 min in room temperature, followed by two washes
and DAPI staining. For negative controls, slides were
incubated with 1 μM unlabeled glybenclamide for 30
min in room temperature prior to addition of 20 nM
FITC conjugated-BODIPY-glybenclamide for 60 min.
Images were obtained using a digital camera and the
Spot Diagnostics Instruments software (Version 4.5 for
Mac OS X) through a Nikon Eclipse E600 (Nikon,
Japan) microscope. Confocal microscopy employed a
Nikon Eclipse TE 200-U (Nikon, Japan) equipped with
EZ C1 laser scanning software. Images were captured
using a 30 μm emission pinhole with a 40× objective.
The criteria used in analysis were consistent through-
out the study of all images. The inspection and analysis
of samples was performed by the same investigator, who
was blinded to the groups of the animals the samples
were obtained from. The prevalence and intensity of
immunofluorescence in somata and nerve fibers were
measured using the Metamorph (Version 7.1; Downing-
town, PA). The intensity of fluorescence within cell tar-
gets was compared to background, as has been
previously used in DRG immunostaining analysis
[16,17]. Target was considered positive when intensity
in area of interest was threefold greater than in back-
ground. This was confirmed by subjective evaluations of
randomly chosen images. By this way, there was a con-
sistent agreement between areas considered positive by
direct visual inspection and areas exhibiting intensity/
background ratio >3. Only cells with clearly visible
nuclei were selected for further analysis. We measured
the areas of the neuronal somata using the ImageJ soft-
ware (Java, version 1.5.0-13; Wayne Rasband, Research
Services Branch, NIH, Bethesda, MD).
Electron microscopy (EM)
For preparing samples for immuno-EM, freshly disso-
ciated rat DRG tissues were high pressure frozen, freeze
substituted in ethanol and 0.5% uranyl acetate, and
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embedded in Lowicryl K11 M resin. Ultrathin sections
were prepared on formvar/carbon coated grids and
incubated with anti-SUR1 or anti-Kir6.2 antibodies,
washed, and then labeled with goat anti-rabbit antibo-
dies conjugated to 10 nm colloidal gold. Sections were
examined in a Hitachi H600 TEM 9 (Hitachi, Japan)
and images recorded using an AMT 1K camera (Dan-
vers, MA).
For preparing samples for measuring SLI by EM, a
mixture of 2% glutaraldehyde and 4% PFA in 0.1 M
sodium cacodylate buffer (pH 7.2) containing 0.5 mM
CaCl2 was applied onto exposed rat DRG in situ. After
approximately 30 s, fixed pieces of the DRG and nerve
were excised and placed into fresh fixative (as above)
and fixed for a further 1 h on ice. Tissues were then
washed in ice-cold buffer, 3 × 5 min changes, then post
fixed with 1% osmium tetroxide and 1.5% potassium
hexacyanoferrate for 2 h on ice. Following post fixation,
the tissues were rinsed 3 × 5 min in distilled water,
dehydrated through graded methanol and embedded in
Embed 812 resin. Ultrathin (60 nm) sections were cut,
stained with saturated uranyl acetate in 25% ethanol fol-
lowed by Reynolds lead citrate and examined in a JEOL
2100 TEM (Japanese Electron Optics, Ltd). The areas of
SLI were measured using the ImageJ software by an
investigator blinded to the experimental group. For con-
sistency reasons, we measured only incisures that tra-
versed the whole width of the myelin sheaths (complete
incisures) [18]. Only longitudinal tissue sections were
obtained for analysis. We examined sections from three
separate sampling sites: from the L5 spinal nerve proxi-
mal to ligation, from within the DRG, and from the dor-
sal root proximal to DRG. The investigator who
captured the images of SLI was blinded to the experi-
mental group.
Electrophysiological recordings
We used electrophysiological recordings to further verify
the specificity of our antibody against the SUR1 subunit,
and to confirm that staining is localized in the plasma-
lemmal membranes of neuronal somata. We tested
whether the anti-SUR1 antibody affected the blocking
effect of glybenclamide on KATP single-channel currents
recorded using the excised inside-out configuration of
the patch-clamp technique. For this reason neurons
from control (SS) rats were preincubated with anti-
SUR1 antibodies (1:60) for 2 h and compared with neu-
rons preincubated in control solution without antibody
at 37°C for the same time. Single-channel KATP currents
were recorded from large diameter neuronal somata at
room temperature (20-25°C) as described previously
[8-10]. Glybenclamide, a selective KATP channel blocker
[19], was obtained from Sigma and diluted daily from 50
mM stocks in DMSO kept at 4°C. The bath (intracellu-
lar) solution contained (in mM): 140 KCl, 10 Hepes, 5
EGTA, and 2 MgCl2. The pipette (extracellular) solution
contained (in mM): 140 KCl, 10 Hepes, 10 d-glucose,
and 0.5 EGTA. The pH of all solutions was adjusted to
7.4 with KOH. Membrane potential was clamped at -60
mV. A conventional 50% current amplitude threshold
level criterion was used to detect open events. Channel
open probability (Po) was determined from the ratios of
the area under the peaks in the amplitude histograms
fitted by a gaussian distribution. Channel activity was
calculated as NPo, where N is the number of observed
channels in the patch, from data samples of 30 s record-
ings duration in the steady state. Mean open time values
were estimated from patches that contained predomi-
nantly one type of single channel opening. The NPo of
the KATP channels was normalized to the baseline NPo
value obtained before the drug at bathing solution with-
out ATP, indicating relative channel activity (relative
NPo).
Statistical analysis
Data were compared between control and SNL DRG, or
between NF200 positive or negative neurons by Stu-
dent’s or Fisher’s exact tests, as appropriate, using the
SPSS 16.0 for Mac statistical software (SPSS Inc, Chi-
cago IL). Concentration-response curves were plotted
using the Prism 4 for Macintosh (GraphPad Software,
Inc) and compared using ANOVA. Areas of SLI were
also compared between groups and sites of sampling by
ANOVA, using the univariate general linear function of
the SPSS, followed by Bonferroni post hoc tests or Stu-
dent’s t test whenever appropriate.
Results
We used 16 control rats with probability of hyperalgesia
scores 0 ± 0% and 9 SNL rats with 42 ± 20% respec-
tively (p < 0.001 versus control).
Expression of KATP subunits at the mRNA level in DRG of
control rats (Fig. 1A)
The mRNA for all KATP channel subunits was detected
in L5 DRG from control rats. Bands of the expected
sizes were detected with primers amplifying Kir6.1 (110
bp), Kir6.2 (168 bp), SUR1 (182 bp) and SUR2 (124 bp)
(Fig. 1A). Our negative control experiments, where the
reverse transcriptase was omitted, produced only faint
nonspecific bands of cDNA, excluding DNA contamina-
tion (data shown in Additional File 1: Figure S1).
Expression of KATP subunits at the protein level in DRG of
control rats (Fig. 1B)
In DRG tissue, Kir6.2 antibody recognized one immunor-
eactive band of 37 kDa, at the expected size of Kir6.2
[20-22]. With antibody against Kir6.1, no bands were
detected in DRG tissue, while a band of 37 kDa was found
in samples from brain tissue [20,22]. In DRG tissue, the
SUR2 antibody detected two expected bands, one at 150
kDa, the expected size for full length SUR, and the other
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at 74 kDa, in agreement with other reported data for splice
variants for the SUR2 subunit [20,22,23]. Finally, the SUR1
antibody detected two prominent bands of 150 kDa and
37 kDa, and one less pronounced band at 125 kDa (Fig.
1B). This is also consistent with SUR1 bands identified by
other studies [20,24].
Rat DRG neurons exhibit SUR1, SUR2, Kir6.2 but not
Kir6.1 immunofluorescence (Fig. 2)
In negative controls, we observed no immunofluores-
cence after omitting all primary antibodies. In BODIPY-
Glybenclamide negative controls, we also observed no
fluorescence after we pre-blocked sections with unla-
belled glybenclamide (data not shown). In positive con-
trols, we obtained staining on samples from rat pancreas
known to express Kir6.2/SUR1; brain known to express
Kir6.2/SUR1 and Kir6.1/SUR1; heart and/or aorta,
wherein Kir6.1/SUR2 is expressed [25] (data shown in
Additional File 1: Figure S1).
In contrast to positive controls in brain and aorta, no
Kir6.1 staining was observed in DRG tissue (Fig. 2A).
Kir6.2 immunofluorescence was present in plasma
membranes, within the cytosol in a diffuse punctuate
pattern, and along the axons (Fig. 2B). In some neurons,
staining was also observed in the nuclear envelope.
Most neurons exhibited SUR1 staining in the plasma
membrane in a continuous, intense pattern, as well as
cytosolic staining that was diffuse and less intense
Figure 1 Expression of KATP channel subunits in DRG at the
mRNA and protein level. A. RT-PCR product bands consistent with
the presence of mRNA encoding KATP channel subunits in DRG from
control rats. Total mRNA was isolated from the L5 DRG. Amplified
products appeared at positions corresponding to the expected base
pair lengths of 168 (Kir6.2), 182 (SUR1), 110 (Kir6.1), 124 (SUR2) and
315 (18S). B. Western blotting using antibodies against KATP channel
subunits in DRG of control rats. Kir6.2 antibody recognized one
immunoreactive band at 37 kDa. SUR1 antibody revealed prominent
immunoreactive bands at 150 and 37 kDa, and a less pronounced
band at 125 kDa. The band at 150 kDa indicates glycosylated SUR1
bound to Kir6.2. Kir6.1 did not detect any band in DRG tissue, while
a band of 37 kDa was detected in samples of brain tissue. Two
immunoreactive bands at 150 and 74 kDa were detected by SUR2
antibody. Molecular size markers are shown on the left.
Figure 2 Presence and distribution of Kir6.2, SUR1, and SUR2
subunits in DRG neurons and satellite glial cells from control
rats. Samples of DRG slices were co-labeled with DAPI, which stains
nuclei (blue), and the antibody against each individual subunit (red)
(A-D). A. Kir6.1 immunofluorescence was absent in DRG. In contrast
the same antibody revealed immunostaining in positive controls (rat
brain and aorta smooth muscle; not shown). B.
Immunofluorescence against Kir6.2 is identified on plasma
membranes (yellow arrowheads) and cytosol (white arrow). Most
satellite glial cells also stained positive for Kir6.2. C.
Immunofluorescence against SUR1 is observed in the plasma
(yellow arrowheads) and nuclear membranes (purple color), as well
as along the axons (single yellow arrowhead). Satellite glial cells also
stained positive. D. Staining against the SUR2 subunit is observed in
the plasma membrane (yellow arrowheads), nuclear membrane
(purple color), and the cytosol (white arrow). Satellite glial cells also
stained positive. In order to confirm the localization of staining in
the plasmalemmal membrane of neurons versus the satellite cell
membrane, we examined dissociated DRG cells, stained with the
same antibodies, using confocal microscopy. These images clearly
showed that neuronal plasmalemmal membrane stained positive for
SUR1 (E), Kir6.2 (F), and SUR2 (G). Nuclear envelops also stained
positive (E and G, single yellow arrowhead). Distinct positive
staining was also observed in satellite cells (G). In E, images
correspond to 5 sequential confocal images of z-projections (with
spacing increments of 1 μm).
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compared to the membrane (Fig. 2C). Anti-SUR1 stain-
ing in the cytosol was punctuate, with regional varia-
tions of the density of staining. Intense SUR1 staining
was also observed on the nuclear envelopes. Finally,
SUR2 staining was present in plasmalemmal and nuclear
membranes, in the cytosol, and also in axons (Fig. 2D).
Most satellite glial cells also stained for Kir6.2, SUR1
and SUR2.
To further distinguish immunostaining localized in the
neuronal plasmalemmal membrane from the adjacent
satellite glial cells, we studied dissociated DRG cells
stained with the same antibodies under confocal micro-
scopy. Neuronal plasmalemmal membrane stained for
SUR1 (Fig. 2E), Kir6.2 (Fig. 2F), and SUR2 (Fig. 2G).
Neuronal nuclear envelopes (Fig. 2E and 2G) and satel-
lite glial cells also stained positive under these condi-
tions. These images confirmed the presence of separate
staining in DRG neurons and in satellite glial cells. Simi-
lar findings regarding the distribution of KATP channel
subunits immunoreactivity were observed in DRG from
rats after SNL.
To test whether the binding target of the anti-SUR1
antibody was part of the actual channel in the neuro-
nal plasmalemmal membrane, and specifically on the
regulatory SUR1 subunit, we obtained single channel
recordings from excised membrane patches, using the
inside-out configuration of the patch-clamp technique,
after adding anti-SUR1 antibody in the bath at 37°C
for 120 min. As in our previous studies [9,10], marked
current activity was observed after patches were
excised into a nucleotide-free solution (Fig. 3A, B). In
neurons preincubated in control solution without anti-
body, these currents were inhibited by glybenclamide
(1-1000 nM) in a concentration-dependent manner
(Fig. 3A, C) within a range which is characteristic for
Kir6.2/SUR1 channels. In neurons pre-incubated with
anti-SUR1 antibody, excised patch recordings also
showed KATP channel activity (Fig. 3D and 3E), but the
blocking effect of glybenclamide, which binds to the
SUR1 subunit, was significantly suppressed compared
to that in the absence of the anti-SUR1 antibody (Fig.
3G). Some small, short lived and infrequent channel
openings are also present in the recordings in Fig. 3B
and 3E, suggestive of inward rectifiers, but since their
activity is limited compared to the dominant KATP cur-
rent activity, they should not have any overall impact
in the analysis. Time-controlled experiments in the
absence of glybenclamide resulted in no KATP channel
activation or inhibition during the same time periods
in both groups (data not shown). These results con-
firmed that the anti-SUR1 antibody has efficacy against
the SUR1 subunit in neuronal plasmalemmal mem-
brane channel.
Co-localization of Kir6.2 with SUR1 subunits in DRG from
control rats (Fig. 4)
In order to determine whether Kir6.2 and SUR1 subu-
nits co-localize in the same neuronal or glial sites, we
further examined the distribution of these subunits in
DRG by co-labeling sections with BODIPY-Glybencla-
mide and anti-Kir6.2. We observed that BODIPY-Gly-
benclamide staining co-localized with anti-Kir6.2
immunofluorescence in the same sites of the plasmalem-
mal membrane in DRG neurons (Fig. 4A-C). Combined
labeling with BODIPY-Glybenclamide and anti Kir6.2
demonstrated punctuate staining of SUR1 colocalized
with Kir6.2 in the cytosol. Additionally, some cells
exhibited intense peri-nuclear, ring-like staining (Fig.
4A-C). These findings indicate that Kir6.2 and SUR1
subunits co-localize, apparently forming heteromulti-
meric KATP channels.
Localization of SUR1 staining in CGRP positive or
negative primary afferent neuronal somata (Fig. 4) from
control rats
Anti-SUR1 antibodies stained DRG neurons of different
diameters. In order to examine if the population of
small nociceptive fibers express KATP channels, we co-
labeled ganglia from 3 control rats with anti-SUR1 and
anti-CGRP antibodies which specifically stain peptider-
gic nociceptors [26,27]. The areas of CGRP+ and
CGRP- neuronal somata were 420.2 ± 290.6 (range
33.7-1389.3) μm2 and 864.9 ± 389.6 (range 299.1-
1719.7) μm2, respectively (p < 0.01). We observed that
antibody against the SUR1 subunit stained most of the
CGRP+ and CGRP- neurons (Fig. 4D-F, Fig. 4G-I). This
indicates the expression of KATP channels in CGRP+
peptidergic nociceptors.
Expression of SUR1 and Kir6.2 subunits in peripheral
nerve fibers from control rats (Fig. 4 and Fig. 5)
Immunofluorescence against SUR1 and Kir6.2 subunits
was also observed along the nerve fibers, in addition to
somata. In the case of anti-SUR1, profiles of staining
included funnel shaped and rectangular patterns (Fig.
4K). In order to elucidate the distribution of these pat-
terns of staining in reference to nodes of Ranvier, we
co-labeled samples with Caspr and SUR1, or Caspr and
Kir6.2 antibodies. SUR1 and Kir6.2 were expressed in
Caspr positive areas, indicating the presence of KATP
channels in paranodal areas (Fig. 4M, Fig. 4P). Addition-
ally, SUR1 fluorescence appeared in funnel shaped pro-
files in areas apart from Caspr positive sites. This
selectively appeared in NF200+ fibers, indicating that
KATP channels containing SUR1 subunits are expressed
in myelinated sheaths.
To further investigate the distribution of these SUR1
positive funnel-shaped patterns at a higher resolution,
we employed EM (Fig. 5) that showed binding of gold-
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Figure 3 Preincubation with anti-SUR1 antibody abolishes the blocking effect of glybenclamide on single KATP channel opening in
excised membrane patches. Neurons preincubated with anti-SUR1 antibody (n = 5, D, E, F; purple) were compared to neurons preincubated
in antibody-free solution (n = 7, A, B, C). Horizontal arrows indicate closed channel. A. Representative trace of KATP channel activity in patch
excised from a neuron preincubated in antibody-free solution. In these neurons glybenclamide inhibited channel activity in a concentration-
dependent fashion. B. Marked channel activity occurred upon excision of patch (vertical arrow in A) into an ATP-free solution. C. Glybenclamide
1000 nM blocked channel activity under control conditions. D. Representative trace of KATP channel activity in patch excised from a neuron
preincubated with anti-SUR1 antibody. E. Excision of patch (vertical arrow in D) into an ATP-free external solution also activated channel. Cell-
free patch exhibited similar KATP single channel activity as in controls (B). F. In contrast to neurons preincubated in antibody-free solution (C),
glybenclamide 1000 nM failed to block channel activity after preincubation with anti-SUR1 antibody. G. Blocking effect of glybenclamide under
control conditions is shown in the concentration-response curve (dotted-line; lower trace). Cumulative application of glybenclamide failed to
block channel activity after preincubation with anti-SUR1 antibody, as indicated by the less steep concentration-response curve in G (solid line;
upper trace). Means ± SD are shown. *:p < 0.05 versus glybenclamide 1 nM; §: p < 0.05 versus control. (Student’s t tests were used for
intergroup, and Bonferroni tests for intragroup post hoc comparisons).
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Figure 4 Colocalization studies in DRG neurons. A-C. Colocalization of BODIPY-Glybenclamide staining of SUR1 subunits (A), with anti-Kir6.2
antibody (B), showing that SUR1 subunits are co-expressed with Kir6.2 subunits in the same complexes (C: merged). D-F. Co-localization of anti-
SUR1 antibody (D) with anti-CGRP antibody (E) in DRG studied under fluorescent microscopy. Merged image (F) shows anti-SUR1
immunofluorescence present in small, CGRP positive neurons, as well as in CGRP negative neurons. G-I. Co-localization of anti-SUR1 antibody (G)
with anti-CGRP antibody (H) in dissociated neurons studied under confocal microscopy. Merged image (I) shows SUR1 immunofluorescence
present in small, CGRP + neurons (arrows), as well as in CGRP negative neurons. K-M. Co-localization of anti-SUR1 antibody (K) with anti-Caspr
antibody (L) in DRG studied under confocal microscopy. Merged image (M) shows that SUR1 immunofluorescence co-localizes with anti-Caspr
staining in paranodal sites. Yellow arrowheads point to SUR1 positive SLI (in K). N-P. Colocalization of anti-Kir6.2 antibody (N) with anti-Caspr
antibody (O) in DRG studied under confocal microscopy. Merged image (P) shows that anti-SUR1 immunofluorescence colocalizes with anti-
Caspr staining in paranodal sites, adjacent to Ranvier’s nodes (White arrows point at paranodal KATP channels). This colocalization of Caspr with
SUR1 or Kir6.2 indicates that KATP channels of the Kir6.2/SUR1 subtype are present in paranodal sites (white arrows) adjacent to nodes of Ranvier.
All samples are from slices within DRG tissue.
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labeled anti-SUR1 and anti-Kir6.2 antibodies on axonal
membrane and in the myelin sheath, within sites that
are characteristic for Schmidt-Lanterman incisures (SLI)
formed by the Schwann cells (Fig. 5C, Fig. 6A). These
findings, together with the characteristic microscopic
funnel-shaped patterns [18,28], indicate the presence of
SUR1-containing KATP channels within SLI.
Distribution of SUR1 expression in NF200+ and NF200-
neurons from control rats, and alterations after axotomy
(Fig. 6)
Inspection of our samples suggested that large neurons
were more likely to express KATP subunits. This might
indicate a cell type-specific expression of KATP channels
predominantly in large, myelinated neurons, in agree-
ment with previous electrophysiological data [10]. In
order to examine this, we co-labeled DRG sections with
antibodies against both SUR1 and NF200, which distin-
guishes DRG neurons that correspond to large, myeli-
nated subpopulation [26,29]. NF200- neurons
correspond to small, unmyelinated C fibers [29,30]. The
areas of NF200+ and NF200- neuronal somata from
control rats were 1056.5 ± 431.8 (range 418.5-2525.2)
μm2 and 385.5 ± 106.9 (range 209.9-677.1) μm2, respec-
tively (p < 0.01). In control neurons, SUR1 is expressed
Figure 5 Distribution of KATP subunits on DRG examined by electron microscopy. Samples from slices within DRG tissue were treated with
antibodies against Kir6.2 or SUR1, which were labeled with gold particles (shown as black dots). A. Anti-Kir6.2 staining on axonal membrane (red
arrow) and myelin sheath (yellow arrowhead). B. Anti-SUR1 staining on axonal membrane (red arrows). C. Anti-SUR1 staining on axonal
membrane (red arrows) and into a SLI (yellow arrowheads). The axons are marked by red asterisks.
Figure 6 Distribution of anti-SUR1 immunofluorescence in the subpopulations of NF200+ and NF200- neurons in control (A-D) and
SNL (E-H) DRG. A, E: Red anti-SUR1 immunofluorescence is observed on plasma and nuclear membranes, satellite glial cells, and along the
peripheral nerve fibers. White arrows point to SLI. These are more intense and funnel shaped in controls (A) compared to SNL (E), wherein SLI
loose their characteristic funnel shape, and appear less intense, thin and disorganized. B,F. Anti-NF 200 staining (green), distinguishes two DRG
neuronal subpopulations, corresponding to larger, myelinated NF200+ and to smaller, non-myelinated NF200- fibers. C,G. Merged images
showing the difference in distribution of SUR1 staining in each neuronal subgroup between SS and SNL DRG. SLI are shown with arrows in C. D,
H: Bright field images. SLI are shown by yellow arrowheads in D. I(1-4). Bargraphs showing the differences in the prevalence of SUR1+ staining
between control (C) and SNL NF200+ (I1) and between control (C) and SNL NF200- neuronal somata (I2), compared by Fisher’s exact tests. I3.
Bargraphs showing the decreased prevalence of SUR1+ SLI between control (C) and SNL axons, compared by Fisher’s exact test. I4. Scatterplots
showing the difference in the intensity of SUR1 immunofluorescence in SLI between axons from SNL versus control DRG. Arbitrary fluorescence
units are used. Comparisons were made by Student’s t test.
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at higher rates in NF 200+ somata (34/60, 56.7%) than
NF200- somata (10/29, 34.5%; p = 0.07; Fig. 6).
The areas of NF200+ and NF200- neuronal somata
from SNL rats were 891.1 ± 250.3 (range 331.3-1392.7)
μm2 and 338.12 ± 68.8 (range 229.7-446.4) μm2, respec-
tively (p < 0.01). In axotomized neurons from SNL rats,
localization and distribution of Kir6.2, SUR1 and SUR2
immunofluorescence was comparable to controls (data
not shown). However, only 34.8% of NF200+ SNL
somata stained positive for SUR1 compared to 56.7%
NF200+ controls (p = 0.02; Fig. 6I1). Within the sub-
group of NF200- neurons, the percentage of somata that
stained positive for SUR1 (62.5%) was unchanged from
controls (p = 0.067; Fig. 6I2).
As shown in Fig. 6I3, fewer SNL axons had SUR1+
SLI (63.8%) compared to control (75.8%; p = 0.021 vs.
control). Exposure parameters under which images were
captured did not differ between control and SNL axons,
allowing us to compare the intensity of fluorescence as
well. Intensity of anti-SUR1 fluorescence in SLI was 12%
less in SNL compared to control (p < 0.01; Fig. 6I4).
The patterns of fluorescence in the SNL axons were
also qualitatively different than in control. In SNL, the
shapes of SUR1+ SLI were more linear and thin com-
pared to thicker and funnel-shaped SUR1+ SLI in con-
trol (Fig. 6A,E). SNL reduced SLI area in peripheral
nerves proximal to axotomy, ganglia, and dorsal roots
(Fig. 7D, F; Table 1).
Discussion
SUR1 or SUR2 subunits always co-assemble with either
Kir6.1 or Kir6.2 subunits into functional KATP channel
octamers [2,19]. Using immunostaining and Western
blots, we showed that peripheral sensory neurons
express SUR1, SUR2 and Kir6.2 protein, but not Kir6.1
protein. We identified this co-localization of Kir6.2 with
SUR1 subunits by staining with antibody against Kir6.2,
and with BODIPY-Glybenclamide, which specifically
binds to SUR1 with high affinity at concentrations <40
nM [15]. Our findings from these experiments highlight
the presence of KATP channels in control and axoto-
mized neurons. KATP channels in DRG neurons are of
the Kir6.2/SUR1 (pancreatic-neuronal) and Kir6.2/SUR2
(cardiac) subtype.
Since suboptimal specificity may limit the reliability of
immunostaining techniques [31], we confirmed the spe-
cificity of our antibodies by Western blots. The size of
the bands that we detected are consistent with those
reported in other studies that have identified KATP chan-
nel subunits. Furthermore, we functionally confirmed
the specificity of our anti-SUR1 antibody by electrophy-
siological recording, in which antibody application elimi-
nated glybenclamide-sensitive current in excised
membrane patches. Use of isoflurane anesthesia as well
as the duration of hypoxia may have affected the record-
ings of potassium currents, as described previously [32].
However, it is unlikely that these factors may have con-
founded the results because all rats were exposed to the
same conditions of anesthesia and the duration of
hypoxia. All these procedures were performed by the
same investigator in the same fashion and by the same
protocol for each animal. Antibodies directed against
channel components such as the SUR1 regulatory subu-
nit may alter active sites of the channel or its interaction
with ligands, and thus can be used as specific inhibitors
[33-35].
Our RT-PCR technique detected mRNA encoding all
KATP channel subunits. However, neither immunostain-
ing nor Western blots detected any Kir6.1 at the protein
level. Either immunohistochemistry and Western blots
were not sensitive enough to detect Kir6.1 protein in
DRG neurons, or Kir6.1 mRNA is not translated into
protein in these neurons [36,37]. However, the same
antibodies did not fail to detect Kir6.1 in brain tissue,
which was used as control, indicating competence of
our antibodies, and, therefore the lack of translation of
Kir6.1 mRNA to protein in DRG neurons.
The biophysical and pharmacological properties of
the KATP current recorded in DRG neurons indicate
that the predominant membrane channel subtype is
the Kir6.2/SUR1, since glybenclamide selectively blocks
this subtype in the concentration range used in our
experiments [10,19]. Immunostaining against SUR2
implies the presence of non-functional Kir6.2/SUR2
subunits.
We were able to identify the distribution of functional
KATP channels and their alterations by axotomy by
staining for SUR1 subunits. Previous reports have vali-
dated the use of anti-SUR1 only to study the cellular
distribution of KATP channels [38]. Identification of
SUR1 subunits in membrane and SLI represents post-
translational co-expression with pore-forming subunits,
because SUR and Kir subunits always combine in func-
tional KATP channels. In contrast, unbound SUR subu-
nits are unstable [39,40].
In addition to neurons, KATP channels are present in
glial satellite and Schwann cells, which are known to
express K+ currents [41-43]. Since KATP channels are
inward rectifiers, our findings are consistent with
reports that Schwann cells express inward rectifying K+
currents [44]. Our findings that satellite and Schwann
cells express KATP channels also help clarify a contro-
versial issue about the presence of Kir6.2-containing
KATP channels in glial cells [45]. KATP channels in these
cells, in cooperation with other Kir channels, may con-
vey glial cell-mediated clearance of extracellular K+,
often termed “K+ spatial buffering” or “K+ siphoning”
[45,46].
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Figure 7 Differences in SLI between control (A,C,E) and SNL (B,D,F) axons examined by fluorescent and electron microscopy. A. SLI in
control DRG. The characteristic funnel-shaped appearance is shown by white arrows. B. Following SNL, SLI proximal to axotomy appear
disorganized, without the characteristic immunofluorescent funnel shape (as in A). Intensity of fluorescence in SLI is lower compared to controls.
C, E. Control DRG samples examined by EM. SLI are shown between yellow arrowheads. D, F. The areas of SLI (also shown between yellow
arrowheads) are decreased proximal to axotomy following SNL, as also presented in details in Table 1. Axons are marked by red asterisks.
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A consistent finding of our study is the presence of
KATP channel subunits in nuclear envelopes of DRG
neurons. These channels may regulate gene expression,
as have identified in other tissues. Specifically in pan-
creatic b-cells, K+ fluxes via nuclear KATP channels
release Ca2+ stored in the nuclear envelope leading to
CREB phosphorylation and gene expression [47]. It is
therefore possible that KATP channels in the nuclei of
DRG neurons play similar roles.
Kir6.2/SUR1 subunits have not been previously identi-
fied in peripheral nerve fibers, although inward rectifying
K+ channels have been detected in paranodal sites
[42,44,48]. The molecular identity of these inward recti-
fiers had not been identified previously, but we now
show that both SUR1 and Kir6.2 co-localize with Caspr +
paranodal areas in axons. This finding implies that KATP
channels are the first inward rectifying channels identi-
fied in paranodal sites. These sites and the nodes of Ran-
vier have high metabolic demands [49]. It is thus possible
that KATP channels regulate excitability at paranodal
sites, and may safeguard these regions of high metabolic
activity from injury during energy depletion [50].
Our novel finding that KATP channels are present in
SLI, is supported by fluorescent microscopy, and more
specifically by EM data, which together confirm the pre-
sence of SUR1 subunits in SLI. Schmidt-Lanterman inci-
sures are accumulations of Schwann cell cytoplasm
enclosed within the myelin lamellae all along the inter-
nodal length of the axon, and also adjacent to nodes of
Ranvier [18,28]. These structures contain abundant gap
junctions that mediate intra- and intercellular communi-
cations [51]. KATP channels regulate opening of gap
junctions in other cell types [52], including astrocytes
[53], and they may do so in SLI as well. SLI are involved
in metabolic functions of the myelin sheath and axon,
including growth, maintenance and axonal support [54].
Because of these functions, SLI have high metabolic
activity and energy demands, which are elevated follow-
ing nerve injury [50]. It is thus possible that KATP chan-
nels in SLI mediate protection against energy depletion.
Part of the supportive functions of glial satellite and
Schwann cells is the synthesis and transfer of ion chan-
nels to neighboring axons [43,55]. Indeed, an exchange
of K+ channels between Schwann cells and neuronal
axons has been shown [56]. Neurons need to supply
500-2000 nodes with channels that undergo rapid turn-
over. However, because axonal transport from the soma
is not always sufficient, especially to the most distant
parts of the fiber, Schwann cells may provide these
channels to axons through SLI intercellular communica-
tions. Therefore, the SUR1 subunits that we have
detected in the SLI may be parts of KATP channels in
transit towards the adjacent axons, or may be functional
constituents of the SLI themselves.
Neurons axotomized by SNL express KATP channel
subunits at the same cellular and histologic locations as
controls. However after injury, NF200+ somata are less
likely to express SUR1 subunits less frequently than
control somata. Like other types of K+ channels [57-59],
KATP channels decrease after nerve injury, due to their
downregulation or to their redistribution to axons.
A novel observation of our study is that the preva-
lence of SUR1 positive SLI, as well as the intensity of
SUR1 immunofluorescence in the SLI, decrease after
nerve injury. Our ultrastructural data from EM show
that the geometrical area of the SLI after nerve injury is
reduced, which may explain diminished SUR1 immuno-
fluorescence. This further indicates disruption of myelin
architecture proximal to the site of axotomy, consistent
with other reports indicating altered SLI architecture in
various peripheral neuropathies [60], including Charcot-
Marie-Tooth [51].
Downregulation or decreased KATP channel activity
may open gap junctions between SLI, between adjacent
Schwann cells, and also between SLI and regenerating
axons, as they do in other tissues [52,53]. These open
gap junctions in Schwann cells transport ATP and other
metabolic substrates to axons [51]. Our observations of
decreased SUR1 at these sites after injury suggests that
withdrawal of KATP channel activity may support neuro-
nal regeneration.
However, considering the alterations we observed in
injured by SNL neurons, dissociated from rats with hyper-
algesia, only comparison with neurons from rats subjected
to the same treatment (SNL) but not exhibiting hyperalge-
sia would indicate whether these changes are pertinent in
the pathogenesis of neuropathic pain. Thus, rats not exhi-
biting neuropathic pain phenotype after SNL would be
appropriate to serve as an additional control group, the
lack of which constitutes a limitation of our study.
Table 1 Areas of Schmidt-Lanterman Incisures in peripheral nerves diminish after painful axotomy.
Area of Schmidt-Lanterman Incisures (μm2)
Dorsal root DRG Peripheral nerve
Control L5 2.7 ± 0.7 (n = 46) 5.3 ± 3.9f (n = 116) 2.3 ± 1.0 (n = 111)
SNL L5 1.6 ± 0.9* (n = 142) 2.9 ± 2.3*,f (n = 117) 0.5 ± 0.3* (n = 116)
Areas of Schmidt-Lanterman Incisures measured in electron microscopy sections obtained from three different sites proximal to axotomy, in comparison with
similar sites in control DRG neurons. Sampling sites were the dorsal root proximal to DRG, the DRG, and the peripheral nerve distal to DRG but proximal to
axotomy. *: p < 0.01 vs control L5 (by Student’s t tests). f:p < 0.01 vs dorsal root and peripheral nerve (by Bonferroni post hoc tests).
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We have previously reported the presence of KATP
channels in DRG neuronal somata using electrophysio-
logical recordings at the single-channel and whole-cell
current level. We now identify the presence of the speci-
fic channel subunits that conduct KATP current not only
in DRG somata but also in peripheral sensory axons,
glial satellite and Schwann cells, including SLI. KATP
channel opening is necessary to control excitability and
neurotransmitter release in peripheral sensory neurons,
as we have previously shown [9]. Another limitation of
this and our previous studies is a lack of description of
the distribution and role of KATP channels at the presy-
naptic afferent terminals in the dorsal horns, although
their presence at these sites is highly likely [61]. KATP
channels may also contribute to neuroprotective func-
tions in DRG as in other neurons [6].
Our previous work has emphasized the role of KATP cur-
rents in DRG neurons, which are the primary determinants
of sensory function. However, lack of the functional confir-
mation of KATP currents in glial cells in contrast to DRG
neurons is another limitation. Further exploration of the
role of KATP channels in glial cell is an important topic, but
the necessary studies should include extensive electrophy-
siological characterization and additional experiments that
will be the subject of separate future investigations.
In glial satellite and Schwann cells, KATP channel
opening may also support metabolic functions, including
K+ siphoning [45]. However, in the peripheral nerves,
recovery from injury may also benefit from loss of KATP
channels, which facilitates restoration through gap junc-
tion opening and facilitated axonal regeneration.
Because of these diverging roles of KATP channels in dif-
ferent neuronal and non-neuronal sites, opposing effects
of KATP channel opening in SLI and myelinated nerve
fibers after painful nerve injury are likely. However, this is
based on speculation. There is a possibility that the effects
on one site may override these on another site, therefore
further studies are necessary to elucidate the in vivo effects
of peripheral application of KATP channel openers for
treating neuropathic pain and neurodegenaration.
Additional file 1: Supplemental Figure Legend. A. Negative controls
for RT-PCR. On negative control experiments, where the reverse
transcriptase was omitted, no amplified products appeared at positions
corresponding to the expected base pair lengths of 168 (Kir6.2), 182
(SUR1), 110 (Kir6.1), 124 (SUR2) and 315 (18S). B. Positive controls for anti-
Kir6.2 antibody (rat brain), anti-SUR1 antibody (rat pancreas), anti-Kir6.1
antibody (rat brain) and anti-SUR2 antibody (mouse cardiac myocyte). All
these areas are known to express KATP channels. Bright field images are
shown on the right of each image. Additional positive control
experiments revealed SUR2 staining in sections from rat aorta (not
shown). Nuclei in myocyte are stained by DAPI.




[ATP]i: cytosolic ATP concentration; DRG: dorsal root ganglion; PBS:
phosphate buffered saline; PFA: paraformaldehyde; RT-PCR: reverse
transcription-polymerase chain reaction; SDS-PAGE: sodium dodecyl sulfate
polyacrylamide gel electrophoresis; PVDF: polyvinylidene fluoride; TBS-T: tris
buffered saline -tween20; DAPI: 4’,6-diamidino-2-phenylindole; GDB: Gelatin
Diphosphate Buffer; FITC: Fluorescein isothiocyanate; BODIPY: boron-
dipyrromethene; TEM: transmission electron microscope; DMSO: Dimethyl
sulfoxide.
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